January 2016 in “Chemistry & Industry” Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.
January 2016 in “Springer eBooks” Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.
August 2026 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft” Topical corticosteroids are highly recommended for Alopecia areata, with systemic corticosteroids and Janus kinase inhibitors recommended for adults, and hair replacement options should be discussed with all patients.
July 2026 in “Advances in Therapy” Clinicians prefer JAK inhibitors that regrow scalp hair quickly and effectively for alopecia areata.
July 2026 in “The scientific and practical journal Dermatology and infectious diseases” Systemic isotretinoin is very effective for treating dissecting cellulitis of the scalp.
Baricitinib is used for severe alopecia areata after trying corticosteroids or other JAK inhibitors.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Baricitinib is used for severe alopecia areata after trying corticosteroids or other JAK inhibitors.
June 2026 in “Current Opinion in Pediatrics” Early, tailored assessment and treatment are crucial for adolescent hair loss, with promising new diagnostic and treatment options.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Alopecia areata causes hair loss and affects mental health, with new treatments like JAK inhibitors offering hope.
June 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Alopecia areata causes hair loss and affects mental health, with new treatments like JAK inhibitors offering hope.
June 2026 in “British Journal of Dermatology” Chance discoveries have led to important skin treatments, but systematic research makes them effective.
Accurate diagnosis and new therapies are crucial for effectively treating certain types of hair loss.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” New treatments for alopecia focus on personalized plans to improve hair regrowth and reduce side effects.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” New treatments for hair loss focus on personalized and regenerative approaches for better results.
May 2026 in “International Journal For Multidisciplinary Research” Leech therapy might help treat alopecia areata by improving blood flow and immune response.
May 2026 in “Frontiers in Oncology” Alopecia areata may lower melanoma risk and does not increase overall skin cancer risk.
May 2026 in “Institutional Repository of the University of Granada (University of Granada)” New treatments for alopecia areata show promise, but their real-world effectiveness and impact on life and sexual health need more study.
May 2026 in “JDDG Journal der Deutschen Dermatologischen Gesellschaft” Use topical corticosteroids for alopecia areata, consider systemic treatments like corticosteroids or JAK inhibitors for severe cases, and inform about cosmetic options.
April 2026 in “Indian Journal of Dermatology” Follicular vitiligo causes hair whitening without skin color change and can be treated for repigmentation.
April 2026 in “Clinical and Experimental Dermatology” Alopecia areata causes significant emotional distress, requiring treatments that focus on mental health and social support, not just hair regrowth.
April 2026 in “Journal of the European Academy of Dermatology and Venereology” Alopecia areata deeply affects life beyond appearance, and effective treatments can restore confidence and improve quality of life.
April 2026 in “Antibodies” The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.
March 2026 in “International Journal of Innovative Technologies in Social Science” Vitiligo is a systemic disease with psychological effects, and new treatments focus on personalized care.
March 2026 in “Actas Dermo-Sifiliográficas” JAK inhibitors are recommended for severe alopecia areata if corticosteroids fail.
March 2026 in “SHILAP Revista de lepidopterología” Rituximab may cause skin issues, but baricitinib can help improve them.
February 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Alopecia affects mental health, causing depression and anxiety, but new treatments can improve both hair growth and quality of life.
February 2026 in “Zenodo (CERN European Organization for Nuclear Research)” Alopecia affects mental health, causing depression and anxiety, but new treatments can help improve both hair growth and quality of life.
February 2026 in “Stem Cell Research & Therapy” Stem cell therapies show promise for hair regrowth in alopecia areata but need more research for safety and effectiveness.
February 2026 in “Journal of Advances in Biology & Biotechnology” Alopecia areata causes unpredictable hair loss and requires personalized treatment.
Dupilumab may worsen hair loss in patients with alopecia areata.